Search
Patexia Community
News and Analysis

Our Members

All »
michelle cipolla
kamal dasari
Bharat Ram Ambati
Abhinandan Deshmukh
Valerio Vitale
Ivan Yeung
Jeff Courchesne
Navid Zanganeh
heta raval
rudy tjandra
RAVI BELUR RAGAVAN
Abed dreams
j g shah shah
jaya singh
Tima Maslyuchenko

Innovation, Technology, and IP News

CAFC's Evolving Stance on Patent Eligibility: Implications for Appeals

The United States Court of Appeals for the Federal Circuit (CAFC) has been at the forefront of shaping patent law in the United States. Among the many facets of patent law that CAFC...

Major Med Device Product Developer GE HealthCare Collaborating with Healthcare Providers

Written by: Kregg Koch For good reasons, including product safety, quality assurance, development of delivery procedures and instructions, it has been a common practice for medical...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Baxalta Inc. v. Genentech, Inc., Appeal No. 22-1461 (Fed. Cir. Sept. 20, 2023) Our Case of the Week focuses on the enablement requirement. It’s the first case...

Enter TitleFederal Circuit Revisits Standard for Enablement of Antibody Claims

Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2021-2299, -2338 (Fed. Cir. Sept. 15, 2023) In a decade-old case that has ...

Prosecution History May Support a Motivation to Combine

Written by: Rhett D. Ramsey & Jacob R. Rosenbaum Elekta Limited v. Zap Surgical Systems, Inc. Before: Reyna, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. ...

Feed tagged as "pharmaceutical":
Patexia Insight 155: Top ANDA Attorneys of 2022
Pedram Sameni Oct 20, 2022
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in ... Read More »
Comment: 0 Favorite (0)
AstraZeneca vs Dr. Reddy's, When Brand and Generic Sue Over Trademark Infringement
Mikele Bicolli Aug 15, 2022
  The FDA evaluates the generic versions of a drug and approves them only if studies show that it is bioequivalent with the... Read More »
Comment: 0 Favorite (0)
The Benefits and Effects of Hatch- Waxman Act Four Decades Later
Mikele Bicolli Jul 27, 2022
In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that... Read More »
Comment: 0 Favorite (0)
How does Patent Law Strengthens Public Health?
Mikele Bicolli May 22, 2022
The pandemic we just went through was one of the examples of how important is the patent system in strengthening the public health... Read More »
Comment: 0 Favorite (0)
How Do Patents Affect The Healthcare Industry?
Mikele Bicolli May 1, 2022
Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound... Read More »
Comment: 0 Favorite (0)
Patexia Insight 118: Top Hatch-Waxman Attorneys of 2021
Pedram Sameni Oct 21, 2021
Earlier in August, we released our second ANDA Litigation Intelligence Report. We analyzed all parties involved in Hatch-Waxman cases and ranked the top law firms and ... Read More »
Comment: 0 Favorite (0)
ENDO PHARMACEUTICALS SOLUTIONS V. CUSTOPHARM INC.
Knobbe Martens Jul 18, 2018
Federal Circuit Summary Before Moore, Linn, and Chen.  Appeal from the United States District Court for the District of Delaware. Summary: A prior art... Read More »
Comment: 0 Favorite (0)
JAZZ PHARMACEUTICALS, INC. v. AMNEAL PHARMACEUTICALS, LLC
Knobbe Martens Jul 18, 2018
Federal Circuit Summary Before Newman, Lourie, and Reyna.  Appeal from the Patent Trial and Appeal Board. Summary:  References were sufficiently... Read More »
Comment: 0 Favorite (0)
Fresh From the Bench: Precedential Patent Cases From the Federal Circuit
Peter Heuser Jul 22, 2017
Written by Peter E. Heuser, Schwabe, Williamson & Wyatt, P.C. The Circuit issued only one precedential patent case this week, reversing a determination of... Read More »
Comment: 0 Favorite (0)
IPR Denied after Board Finds Asserted PCT Publication Not Entitled to Priority Application’s Filing Date under Pre-AIA 35 U.S.C. § 102(e) Prior Art Theory
Knobbe Martens Feb 15, 2017
Written by Daniel K. Yarbrough, Ph.D. and Nathanael R. Luman, Ph.D. The PTAB denied institution of an IPR based on patent owner’s challenge to the prior art ... Read More »
Comment: 0 Favorite (0)
Supreme Court Grants Certiorari in Amgen v. Sandoz
Knobbe Martens Feb 2, 2017
Written by Robert J. Hilton, Ph.D. and Jing Liu, Ph.D. On January 13, 2017, the Supreme Court granted certiorari in Amgen v. Sandoz, 794. f. 3d 1347 (Fed. Cir... Read More »
Comment: 0 Favorite (0)
22 Novel Drugs Approved by FDA in 2016
Knobbe Martens Feb 1, 2017
Written by Jane Xia and Jason J. Jardine Every year, the FDA’s Center for Drug Evaluation and Research (CDER) approves new medications. Some medications are ... Read More »
Comment: 0 Favorite (0)
New device will speed up drug development
Ann Conkle May 1, 2012
Two Michigan State University researchers have invented a protein purifier that will make  pharmaceutical production quicker and cheaper. Chemists Merlin... Read More »
Comment: 0 Favorite (1)
What happens to medical hazardous waste?
Valerie Clark Apr 6, 2012
Ever wonder what happens to medical hazardous waste?  When research and health care facilities dispose of hazardous waste, there are certain guidelines --... Read More »
Comment: 0 Favorite (0)
Menu